TIPE2 Play a Negative Role in TLR4-Mediated Autoimmune T Helper 17 Cell Responses in Patients with Myasthenia Gravis (Q40394415)

20 September 2017

title

TIPE2 Play a Negative Role in TLR4-Mediated Autoimmune T Helper 17 Cell Responses in Patients with Myasthenia Gravis (English)

1 reference

20 September 2017

0 references

0 references

Yong Zhang

1

1 reference

20 September 2017

Zhen Shao

2

1 reference

20 September 2017

Xiuying Zhang

3

1 reference

20 September 2017

Xiao Jia

4

1 reference

20 September 2017

Yan Xia

5

1 reference

20 September 2017

Yanyan Zhang

6

1 reference

20 September 2017

Ning Xin

7

1 reference

20 September 2017

Mingfeng Guo

8

1 reference

20 September 2017

Jing Chen

9

1 reference

20 September 2017

ShuangShuang Zheng

10

1 reference

20 September 2017

YuZhong Wang

11

1 reference

20 September 2017

Linlin Fu

12

1 reference

20 September 2017

Ruiguo Dong

13

1 reference

20 September 2017

Chenghua Xiao

14

1 reference

20 September 2017

Deqin Geng

15

1 reference

20 September 2017

Yonghai Liu

16

1 reference

20 September 2017

publication date

24 October 2015

1 reference

Journal of Neuroimmune Pharmacology

20 September 2017

published in

1 reference

20 September 2017

volume

10

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

635-644

1 reference

Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Toll-like receptors: a family of pattern-recognition receptors in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

CCL2 recruitment of IL-6-producing CD11b+ monocytes to the draining lymph nodes during the initiation of Th17-dependent B cell-mediated autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Increased toll-like receptor 4 expression in thymus of myasthenic patients with thymitis and thymic involution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

B-cell memory and primary immune deficiencies: interleukin-21 related defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

A different TIPE of immune homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Seropositive myasthenia gravis: a nationwide epidemiologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Identification of a novel tumor necrosis factor-alpha-inducible gene, SCC-S2, containing the consensus sequence of a death effector domain of fas-associated death domain-like interleukin- 1beta-converting enzyme-inhibitory protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

The expression and significance of TIPE2 in peripheral blood mononuclear cells from asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Potent intestinal Th17 priming through peripheral lipopolysaccharide-based immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

TLR-4 ligation of dendritic cells is sufficient to drive pathogenic T cell function in experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Mechanisms associated with the pathogenicity of antibodies against muscle-specific kinase in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Mycoplasma superantigen initiates a TLR4-dependent Th17 cascade that enhances arthritis after blocking B7-1 in Mycoplasma arthritidis-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

The biological functions of T helper 17 cell effector cytokines in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Lipopolysaccharide directly stimulates Th17 differentiation in vitro modulating phosphorylation of RelB and NF-κB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Effect of IL-17A blockade with secukinumab in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Th17 cells in inflammation and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Possible involvement of toll-like receptors in the pathogenesis of myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Roles of TIPE2 in hepatitis B virus-induced hepatic inflammation in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Crystal structure of TIPE2 provides insights into immune homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Paeoniflorin abrogates DSS-induced colitis via a TLR4-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

Expression of interleukin-22 in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9638-5

The effects of TLR activation on T-cell development and differentiation

21 January 2018

1 reference

12 December 2020

Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients

1 reference

12 December 2020

Increased serum interleukin-17 levels in patients with myasthenia gravis

1 reference

12 December 2020

TLR4 and CD14 receptors expressed in rat pineal gland trigger NFKB pathway.

1 reference

12 December 2020

Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses

1 reference

12 December 2020

Innate immunity in myasthenia gravis thymus: Pathogenic effects of Toll-like receptor 4 signaling on autoimmunity

1 reference

12 December 2020

1 reference

12 December 2020

Tumor necrosis factor-alpha, lymphotoxin, interleukin (IL)-6, IL-10, IL-12 and perforin mRNA expression in mononuclear cells in response to acetylcholine receptor is augmented in myasthenia gravis

1 reference

12 December 2020

10.1007/S11481-015-9638-5

Identifiers

DOI

1 reference

20 September 2017

1 reference